5 reports

APTA-## - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description APTA-## APTAHEM AB NA SEATTLE CHILDREN' S RESEARCH INSTITUTE R& D Progress Research and Development Brief APTA-## IS UNDER DEVEL

  • Blood Disease
  • Pharmaceutical
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company

Mechanism Of Action R& D Progress Research and Development Brief AV-## IS UNDER DEVELOPMENT FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTION.

  • Antiviral
  • Hepatitis
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company

Vertex has research and development (R& D) sites and commercial offices in the US, Europe, Canada and Australia.

  • Antiviral
  • Hepatitis
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company

R& D Progress Research and Development Brief Company reported that the drug candidate has demonstrated superior activity in tumors where PD-## monotherapy or PD-##/ LAG-## monoclonal antibody combo has shown activity.

  • Immunotherapy
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • MacroGenics, Inc.
  • BMS-986205
  • BMS-986147

Other Developmental Activities R& D Progress Research and Development Brief Licensing and Collaboration Product Description SMALL MOLECULES TO INHIBIT BETA SECRETASE ## FOR ALZHEIMER' S DISEASE Small molecules are under development for Alzheimer' s disease.

  • Monoclonal Antibody
  • Research And Development
  • Targeted Therapy
  • Therapy
  • Bristol-Myers Squibb Company